Ivonescimab Delays Lung Cancer Progression in EGFR-Mutated Disease

(MedPage Today) — Adding ivonescimab to chemotherapy prolonged progression-free survival (PFS) in previously treated advanced EGFR-mutant non-small cell lung cancer (NSCLC), but failed to significantly improve overall survival (OS), the phase…

Source link : https://www.medpagetoday.com/meetingcoverage/iaslc/117380

Author :

Publish date : 2025-09-09 19:22:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

Ivonescimab Delays Lung Cancer Progression in EGFR-Mutated Disease

‘Great Migration’ involves far fewer wildebeest than we had thought

CDC Autism Data Reviewed; Gabapentin Prescribing Concerns; Smoking and Parkinson’s

Related Posts

Rise in number of people in the UK facing hunger says charity

Healthy Habits Cut Functional Constipation Risk by 40%

Exercise Training Tops Standard Care in MASH Resolution

Dermatologist: Urticaria Management Not Just for Allergists

More children are obese than underweight, Unicef warns

Alzheimer’s blood test could ‘revolutionise’ diagnosis

Rise in number of people in the UK facing hunger says charity

Healthy Habits Cut Functional Constipation Risk by 40%

Exercise Training Tops Standard Care in MASH Resolution

Dermatologist: Urticaria Management Not Just for Allergists

More children are obese than underweight, Unicef warns

Alzheimer’s blood test could ‘revolutionise’ diagnosis

Iridescent mammals are much more common than we thought

RFK Jr.’s Latest MAHA Report Calls for More Scrutiny of Vaccines and Autism

Categories

Archives